Combined Effects of Bioactive Compounds in Lipid Profile
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 118 participants.
Also called NCT01562080
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 118 participants
- Sponsor
- Rottapharm Spain
- Registry
-
NCT01562080
-
- Other papers using this trial's data
- Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT01562080. Randomized; double masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2012-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Combined Effects of Bioactive Compounds in Lipid Profile
- Acronym
- ARM-PLUS-LDL
- Condition
- Hyperlipidemia
- Condition
- Low-density-lipoprotein-type
- Condition
- Elevated Triglycerides
- Intervention (Dietary supplement)
- Armolipid Plus
- Intervention (Dietary supplement)
- placebo
- Lead sponsor
- Rottapharm Spain
- Collaborator
- Centro Tecnológico de Nutrición y Salud
Record details
- Record id
cardio:ct-nct01562080- Content hash
5f97fb2fbdce529078609db960870ef6d74ecfcbdabbe2242399665b79dc0855